A pilot trial of the mTOR (mammalian target of rapamycin) inhibitor RAD001 in patients with advanced B-CLL

200861 citationsJournal Article

Authors

Good health and well-being

Published in: Annals of Hematology

Volume 88, Issue 3, pp. 221-227

Field-Weighted Citation Impact: 4.40